Clinical Trial for Oral Formula of Vanillin and Wheat Germ Oil for Treatment of Mild and Moderate COVID-19 Viral Disease

Inclusion Criteria: 1. PCR confirmed diagnosis for COVID-19. 2. Age ≥18 years. 3. Both genders 4. The disease started within 7 days (ideally 72 hours) of diagnosis or clinical deterioration. 5. Patients diagnosed as mild or moderate Exclusion Criteria: 1. Patients diagnosed with severe Illness: Individuals who have SpO2 \<92% on room air at sea level, a ratio of arterial partial pressure of oxygen to fraction of inspired oxygen (PaO2/FiO2) \<300 mm Hg, respiratory frequency \>30 breaths/min, or lung infiltrates \>50%. 2. General: advanced kidney disease; advanced liver disease; pregnancy (known or potential) or lactation, and advanced cardiovascular diseases. 3. Allergy to Vanilla flavor, vanillin, or wheat germ oil 4. Active cancer